From: Clinical features and outcome of corneal opacity associated with congenital glaucoma
Clinical characteristics | No of patients | % | |
---|---|---|---|
Gender | |||
Female | 77 | 39.9 | |
Male | 116 | 60.1 | |
Laterality | |||
Bilateral | 127 | 65.8 | |
Unilateral | Rt | 26 | 13.5 |
Lt | 40 | 20.7 | |
IOP of involved eyes at presentation (mmHg) | |||
Involved eyes (range) | 28.3 ± 9.3 (9.0–54.7) | ||
Uninvolved eyes (range) | 12.9 ± 2.9 (6.0–29.0) | ||
P value | < 0.0001 | ||
Corneal diameter (Horizontal, mm) | |||
Involved eyes (range) | 12.5 ± 1.2 (7.0–16.5) | ||
Uninvolved eyes (range)) | 10.9 ± 0.9 (9.0–11.5) | ||
P value | < 0.0001 | ||
Systemic comorbidity | 36 | 18.7 | |
Sturge-Weber syndrome | 25 | 12.9 | |
Congenital heart disease | 4 | 2.1 | |
Neurofibromatosis | 2 | 1.0 | |
TORCH | 2 | 1.0 | |
Cerebral palsy | 1 | 0.5 | |
Wilms tumor | 1 | 0.5 | |
Chromosomal abnormality | 1 | 0.5 | |
Ocular comorbidity | 38 | 19.7 | |
Aniridia | 14 | 7.3 | |
Peters anomaly | 7 | 3.6 | |
Cataract | 4 | 2.1 | |
Posterior segment anomaly | 13 | 6.7 |